Expert Consensus Recommendations for Clinical Use of the AYON Body Contouring System in Ultrasound-Assisted Liposuction: A Modified Delphi Study With Early Post-Market Observations

Clicks: 13
ID: 329514
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #93 of 125 articles by views in Aesthetic Surgery Journal Open Forum

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 125 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Ultrasound-assisted liposuction (UAL) is widely used in aesthetic body contouring to facilitate adipose tissue fragmentation and aspiration. Advances in device technology have focused on improving energy delivery, procedural efficiency, and workflow integration. The AYON™ Body Contouring System (Apyx Medical Corporation, Clearwater, FL; AYON UAL) is a recently introduced UAL platform that integrates infiltration, ultrasonic fragmentation, and aspiration within a single system. Objectives To develop device-specific expert consensus recommendations for the clinical use of the AYON UAL platform. Methods A structured modified Delphi process was conducted with an expert panel of aesthetic surgeons experienced in ultrasound-assisted liposuction and clinical use of the AYON UAL platform. Panelists participated in iterative survey rounds and a moderated consensus meeting to evaluate procedural technique, workflow, and safety considerations. Consensus thresholds were predefined, and statements meeting agreement criteria were incorporated into the final recommendations. A concurrent Post-Market Clinical Follow-up (PMCF) survey was analyzed separately to provide descriptive context regarding early real-world platform use. Results Consensus was achieved across key aspects of AYON UAL use. Following refinement and consolidation, 19 consensus statements were unanimously confirmed, with additional consensus findings providing practical context across key domains of device use. The PMCF survey demonstrated broad early clinical adoption across a range of body-contouring procedures and infrequent intraoperative device-related issues. Conclusions This modified Delphi consensus provides device-specific recommendations for the clinical use of the AYON UAL platform. Together with descriptive early PMCF findings, these recommendations provide a practical framework to support clinical adoption, procedural standardization, education, and future clinical research.
Reference Key
openalex_W7214088920 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Paul Vanek, Paul G. Ruff, Barry E. DiBernardo, Charles J. Galanis, Michael Kluska, Melinda Lacerna Kimbrell, David Shafer, Johnny Franco
Are you one of these authors? Claim your profile
Journal Aesthetic Surgery Journal Open Forum
Year 2026
DOI
10.1093/asjof/ojag184
URL
https://doi.org/10.1093/asjof/ojag184
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.